Measuring blood levels of homocysteine, an medlinkamino acid/medlink, can predict a person's risk of developing medlinkobstructive sleep...
Vous n'êtes pas connecté
Blood tests offer a promising method to predict a person's risk of developing obstructive sleep apnea by measuring levels of specific biomarkers.
Measuring blood levels of homocysteine, an medlinkamino acid/medlink, can predict a person's risk of developing medlinkobstructive sleep...
Measuring blood levels of homocysteine, an medlinkamino acid/medlink, can predict a person's risk of developing medlinkobstructive sleep...
FRIDAY, June 28, 2024 -- Metabolic surgery is associated with significantly lower risk of major adverse cardiovascular events (MACE) compared with...
In recent research led by the University of California San Diego School of Medicine, scientists have found a new potential treatment for obstructive...
WEDNESDAY, June 26, 2024 -- Tirzepatide reduces the apnea-hypopnea index (AHI) among individuals with moderate-to-severe obstructive sleep apnea and...
Eli Lilly (LLY) files for the approval of tirzepatide to treat obstructive sleep apnea in adults with obesity in the United States. If approved, sales...
Researchers are developing a portable sleep apnea detection device that patients can wear on their fingertips or wrists. This innovation aims to...
MONDAY, June 24, 2024 -- Specific steps can be taken to reduce the risk of potentially fatal reactions to anti-seizure medications, researchers...
Cleveland Clinic study reveals that weight loss surgery significantly reduces the risk of heart complications by 42% and the risk of death by 37% in...
More than 85% of women – and more than 300 million people worldwide at any given time – use hormonal contraceptives for at least five years of...